Jagdish Dore’ inducted into the Board as Managing Director of Matrix Laboratories
Matrix Laboratories has posted a Net Sales of Rs.9386.33 Mio on a stand alone basis reflecting an increase of 25.3% over the previous financial year. Out of the total revenues, APIs (active pharmaceutical ingredients) accounted for 77% and FDFs (finished dosage forms) accounted for the balance.
Matrix Laboratories Limited announced the appointment of Jagdish Viswanath Dore’ as CEO. Mr. Dore’ will assume the responsibilities of Rajiv Malik who became Executive Vice President and Head of Global Technical Operations for Mylan Inc. (NYSE: MYL) in October 2007and has been serving as interim CEO for Matrix, a majority-owned subsidiary of Mylan.
Corporate Profile | Products | Investor Relations | News Room | Careers | Contact UsManufacturing | Quality Assurance | Environment, Health & Safety | R & D © 2003 Matrix Laboratories Limited. All rights reserved. This site is best viewed in IE 4 or later or Netscape 4.7 or laterDesigned and Developed by emazines software pvt. ltd.
